Wealthspire Advisors, LLC Abb Vie Inc. Transaction History

Wealthspire Advisors, LLC

$9.71 Billion
Q3 2024

A detailed history of Wealthspire Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Wealthspire Advisors, LLC holds 55,754 shares of ABBV stock, worth $9.87 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

55,754

Previous 49,673 12.24%

Holding current value

$9.87 Million

Previous $8.52 Million 29.24%

% of portfolio

0.11%

Previous 0.11%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$163.84 - $199.33 $996,311 - $1.21 Million	6,081 Added 12.24%	55,754 $11 Million
Q2 2024 Aug 08, 2024	SELL	$154.79 - $180.76 $559,565 - $653,447	-3,615 Reduced 6.78%	49,673 $8.52 Million
Q1 2024 May 06, 2024	SELL	$159.82 - $182.1 $322,516 - $367,477	-2,018 Reduced 3.65%	53,288 $9.7 Million
Q4 2023 Feb 06, 2024	SELL	$137.6 - $154.97 $24,355 - $27,429	-177 Reduced 0.32%	55,306 $8.57 Million
Q3 2023 Nov 06, 2023	BUY	$133.59 - $154.65 $1.21 Million - $1.4 Million	9,072 Added 19.55%	55,483 $8.27 Million
Q2 2023 Jul 31, 2023	SELL	$132.51 - $164.9 $73,013 - $90,859	-551 Reduced 1.17%	46,411 $6.25 Million
Q1 2023 May 09, 2023	SELL	$144.61 - $166.54 $557,182 - $641,678	-3,853 Reduced 7.58%	46,962 $7.48 Million
Q4 2022 Feb 13, 2023	BUY	$138.31 - $165.87 $356,563 - $427,612	2,578 Added 5.34%	50,815 $8.22 Million
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $59,857 - $68,652	446 Added 0.93%	48,237 $6.47 Million
Q2 2022 Aug 09, 2022	BUY	$137.62 - $174.96 $433,915 - $551,648	3,153 Added 7.06%	47,791 $7.32 Million
Q1 2022 May 09, 2022	SELL	$131.98 - $163.75 $1.38 Million - $1.71 Million	-10,433 Reduced 18.94%	44,638 $7.24 Million
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $3.76 Million - $4.76 Million	35,007 Added 174.48%	55,071 $7.46 Million
Q3 2021 Nov 15, 2021	BUY	$106.4 - $120.78 $1.14 Million - $1.3 Million	10,739 Added 115.16%	20,064 $2.16 Million
Q2 2021 Aug 13, 2021	SELL	$105.21 - $117.21 $2.87 Million - $3.2 Million	-27,263 Reduced 74.51%	9,325 $1.05 Million
Q1 2021 May 17, 2021	BUY	$102.3 - $112.62 $684,796 - $753,878	6,694 Added 22.39%	36,588 $3.96 Million
Q4 2020 Feb 16, 2021	SELL	$80.49 - $108.67 $930,866 - $1.26 Million	-11,565 Reduced 27.9%	29,894 $3.2 Million
Q3 2020 Nov 16, 2020	BUY	$85.91 - $100.83 $385,392 - $452,323	4,486 Added 12.13%	41,459 $3.63 Million
Q2 2020 Aug 14, 2020	BUY	$73.37 - $98.18 $292,012 - $390,756	3,980 Added 12.06%	36,973 $3.63 Million
Q1 2020 May 12, 2020	BUY	$64.5 - $97.79 $1.5 Million - $2.27 Million	23,205 Added 237.08%	32,993 $2.51 Million
Q4 2019 Feb 14, 2020	BUY	$72.13 - $90.25 $89,801 - $112,361	1,245 Added 14.57%	9,788 $867,000
Q3 2019 Nov 12, 2019	BUY	$62.98 - $75.72 $283,850 - $341,270	4,507 Added 111.67%	8,543 $647,000
Q2 2019 Aug 13, 2019	BUY	$65.7 - $83.98 $265,165 - $338,943	4,036 New	4,036 $293,000
Q1 2019 May 08, 2019	SELL	$77.14 - $90.79 $135,534 - $159,518	-1,757 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$77.85 - $96.01 $136,782 - $168,689	1,757 New	1,757 $162,000

Others Institutions Holding ABBV

# of Institutions

3,848

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $313B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealthspire Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealthspire Advisors, LLC with notifications on news.

Account

Wealthspire Advisors, LLC Abb Vie Inc. Transaction History